Quantitative open-access HPLC analysis: a new calibration approach

Article

Pharmaceutical Technology Europe

Pharmaceutical Technology EuropePharmaceutical Technology Europe-10-01-2010
Volume 22
Issue 10

A novel tool enables users to generate reliable data for yields in solution and for assays of isolated solids using high?performance liquid chromatography without having to prepare standards.

A novel tool enables users to generate reliable data for yields in solution and for assays of isolated solids using high‑performance liquid chromatography without having to prepare standards. The authors discuss the approach taken to develop the tool, its associated protocols and how it can be used to calculate data.

Read the full article here

Articles in this issue
Validating Single-Use Systems
Validating Single-Use Systems
EGA Position On The EC's Proposal For A Falisifed Medicines Directive
i1-687924-1408624996803.jpg
Green is the word
Using Certified Reference Material to Produce Compliant Water Purity Data
Using Certified Reference Material to Produce Compliant Water Purity Data
i2-687920-1408625003549.gif
News
The Pros And Cons Of Single-Use Systems
i2-687918-1408625010027.gif
Europe: A Future Leader in Vaccines?
Developing A Quality Agreement Template For Single-Use Systems
Developing A Quality Agreement Template For Single-Use Systems
Online Monitoring Of Continuous Hot Melt Extrusion
Online Monitoring Of Continuous Hot Melt Extrusion
An All-Round Excipient For Direct Compression
An All-Round Excipient For Direct Compression
Quantitative open-access HPLC analysis: a new calibration approach
i1-182996-1408680981782.jpg
Braille packaging & European generics growth
Recent Videos
Drug Digest: Strategic Partnerships
Roger Viney from ICE Pharma discusses the quality and compliance issues surrounding the use of animal-derived ingredients in the bio/pharma industry.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

EMA Recommends Five New Medicines for Approval

Patrick Lavery
March 28th 2025
Article

Three of the five are biosimilars, and seven additional medicines received recommendations for indication extensions.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Issues Warning Letter to Aspen Biopharma Labs for API Manufacturing Deviations

Feliza Mirasol
March 27th 2025
Article

In the latest of a series of warning letters to India-based API manufacturers, FDA issued a warning letter to Aspen for deviations in CGMP in the production of APIs.

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

CARBOGEN AMCIS Receives GMP Certification Following Successful ANSM Inspection

Patrick Lavery
March 26th 2025
Article

The company’s state-of-the-art sterile drug product manufacturing site in Saint-Beauzire, France, opened in February 2023.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Benuvia Awarded NIH Contract for GMP Synthesis of Psilocybin, Other Drug Substances

Patrick Lavery
March 25th 2025
Article

The contract will support R&D of high-quality APIs for substance use disorders and mental health conditions, starting with synthesis and scale-up of psilocybin, which is derived from mushrooms.